These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8977570)

  • 1. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
    de Crevoisier R; Mazeron JJ
    Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.
    Prades JM; Lallemant B; Garrel R; Reyt E; Righini C; Schmitt T; Remini N; Saban-Roche L; Timoshenko AP; Trombert B; Guerrier B
    Acta Otolaryngol; 2010; 130(1):150-5. PubMed ID: 19449227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
    Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
    J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie.
    Mertens R; Granzen B; Lassay L; Gademann G; Hess CF; Heimann G
    Cancer; 1997 Sep; 80(5):951-9. PubMed ID: 9307197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction polychemotherapy before radiotherapy in carcinoma of the cavum. The experience of the Ibn Rochd-Casablanca Oncology Centre].
    Samlali R; Acharki A; Sahraoui S; Benider A; Kahlain A
    Bull Cancer Radiother; 1996; 83(2):111-4. PubMed ID: 8688217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
    Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
    Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.
    Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK
    Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis.
    Lin YS; Lin LC; Lin SW
    Laryngoscope; 2009 Jul; 119(7):1348-52. PubMed ID: 19402154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
    Farrell PJ
    Nat Clin Pract Oncol; 2005 Jan; 2(1):14-5. PubMed ID: 16264847
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current role for induction chemotherapy in head and neck tumors].
    Dietz A; Keilholz U; Werner J; Hagen R; Flentje M; Iro H
    Laryngorhinootologie; 2008 Apr; 87(4):237-43; discussion 244. PubMed ID: 18365986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neoadjuvant radiochemotherapy for squamous cell carcinoma of the oral cavity].
    Bootz F
    HNO; 2008 Feb; 56(2):183-4. PubMed ID: 18231725
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma.
    Kutter J; Ozsahin M; Monnier P; Stupp R
    Eur Arch Otorhinolaryngol; 2005 Jan; 262(1):1-7. PubMed ID: 15004704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.
    Lee AW; Lau WH; Tung SY; Chua DT; Chappell R; Xu L; Siu L; Sze WM; Leung TW; Sham JS; Ngan RK; Law SC; Yau TK; Au JS; O'Sullivan B; Pang ES; O SK; Au GK; Lau JT;
    J Clin Oncol; 2005 Oct; 23(28):6966-75. PubMed ID: 16192584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of chemotherapy in the treatment of cancer of the cavum (UCNT): apropos of 47 cases].
    Poupart M; Damiano J; Bolot G; Biron P; Caldentey L; Ardiet JM; Pignat JC
    Bull Cancer; 1994 May; 81(5):366-70. PubMed ID: 7538361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.